Cost-Effectiveness of Direct Non-Vitamin K Oral Anticoagulants Versus Vitamin K Antagonists for the Management of Patients with Non-Valvular Atrial Fibrillation Based on Available "Real-World" Evidence: The Italian National Health System Perspective.
Valentina LorenzoniSalvatore PirriGiuseppe TurchettiPublished in: Clinical drug investigation (2021)
The beneficial effect of DOACs on containing events showed in RWE had the potential to offset drug-related costs, thus improving the sustainability of treatment for non-valvular AF in daily clinical practice.
Keyphrases
- oral anticoagulants
- atrial fibrillation
- direct oral anticoagulants
- clinical practice
- left atrial
- catheter ablation
- left atrial appendage
- heart failure
- percutaneous coronary intervention
- physical activity
- emergency department
- drug induced
- coronary artery disease
- human health
- aortic valve
- mitral valve
- smoking cessation